FDA Inspection 1080987 — Sinopep-Allsino Biopharmaceutical Co., Ltd.
The FDA completed an inspection of Sinopep-Allsino Biopharmaceutical Co., Ltd. on Jan 18, 2019 in Lianyungang. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 18, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lianyungang (China)